There is increasing evidence now to suggest that individuals are less likely to respond to cardiac resynchronization therapy (CRT) if the LV lead is placed over an area of underlying scar tissue. As the posterolateral cardiac vein is frequently used, ensuring viability of these walls is of paramount importance.
This case helps to demonstrate the utility of MCE-derived viability assessment for determining optimal LV lead positioning.
Our mission: To reduce the burden of cardiovascular disease.
© 2019 European Society of Cardiology. All rights reserved.